keyword
https://read.qxmd.com/read/38691816/serial-postoperative-circulating-tumor-dna-assessment-has-strong-prognostic-value-during-long-term-follow-up-in-patients-with-breast-cancer
#1
JOURNAL ARTICLE
Jacqueline A Shaw, Karen Page, Evie Wren, Elza C de Bruin, Ekaterina Kalashnikova, Robert Hastings, Rob McEwen, Eddie Zhang, Marc Wadsley, Emmanuel Acheampong, Derek Renner, Kelly L T Gleason, Bana Ambasager, Daniel Stetson, Daniel Fernandez-Garcia, David Guttery, Rebecca C Allsopp, Angel Rodriguez, Bernhard Zimmermann, Himanshu Sethi, Alexey Aleshin, Minetta C Liu, Cathy Richards, Justin Stebbing, Simak Ali, Farah Rehman, Susan Cleator, Laura Kenny, Samreen Ahmed, Anne C Armstrong, R Charles Coombes
PURPOSE: Here, we report the sensitivity of a personalized, tumor-informed circulating tumor DNA (ctDNA) assay (Signatera) for detection of molecular relapse during long-term follow-up of patients with breast cancer. METHODS: A total of 156 patients with primary breast cancer were monitored clinically for up to 12 years after surgery and adjuvant chemotherapy. Semiannual blood samples were prospectively collected, and analyzed retrospectively to detect residual disease by ultradeep sequencing using ctDNA assays, developed from primary tumor whole-exome sequencing data...
April 2024: JCO Precision Oncology
https://read.qxmd.com/read/38691463/protocol-to-prepare-muc1-glycopeptide-vaccines-and-evaluate-immunization-effects-in-mice
#2
JOURNAL ARTICLE
Ye Wu, Yang Zhou, Yajing Guo, Yi Ling, Yiliang Li, Hui Cai
The tumor-associated mucin MUC1 is overexpressed in almost all types of epithelial tumor tissues, making it an attractive target antigen for cancer immunotherapy. Here we present a protocol to prepare MUC1 glycopeptide vaccines and to evaluate immunization effects in mice. We describe steps for synthesizing glycopeptide antigen and conjugating it with carrier protein to make vaccine candidates. We then detail procedures for mice immunization, antibody response evaluation, and cellular immune response. For complete details on the use and execution of this protocol, please refer to Cai et al...
April 30, 2024: STAR protocols
https://read.qxmd.com/read/38690738/enhancing-anticancer-activity-of-macrophages-through-rational-drug-combinations
#3
JOURNAL ARTICLE
Gordon B Mills, Marilyne Labrie
Targeting tumor-associated macrophages (TAMs) is an emerging approach being tested in multiple clinical trials. TAMs, depending on their differentiation state, can exhibit pro- or antitumorigenic functions. For example, the M2-like phenotype represents a protumoral state that can stimulate tumor growth, angiogenesis, metastasis, therapy resistance, and immune evasion by expressing immune checkpoint proteins. In this issue of the JCI, Vaccaro and colleagues utilized an innovative drug screen approach to demonstrate that targeting driver oncogenic signaling pathways concurrently with anti-CD47 sensitizes tumor cells, causing them to undergo macrophage-induced phagocytosis...
May 1, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38690273/tertiary-lymphoid-structures-in-cancer-maturation-and-induction
#4
REVIEW
Yulu Chen, Yuhao Wu, Guorong Yan, Guolong Zhang
Tertiary lymphoid structure (TLS) is an ectopic lymphocyte aggregate formed in peripheral non-lymphoid tissues, including inflamed or cancerous tissue. Tumor-associated TLS serves as a prominent center of antigen presentation and adaptive immune activation within the periphery, which has exhibited positive prognostic value in various cancers. In recent years, the concept of maturity regarding TLS has been proposed and mature TLS, characterized by well-developed germinal centers, exhibits a more potent tumor-suppressive capacity with stronger significance...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38688839/a-case-of-gallbladder-cancer-with-trousseau-syndrome-successfully-treated-using-radical-resection
#5
JOURNAL ARTICLE
Akari Masunaga, Motoyasu Tabuchi, Shinya Sakamoto, Rika Yoshimatsu, Manabu Matsumoto, Jun Iwata, Takehiro Okabayashi
Trousseau syndrome is characterized by cancer-associated systemic thrombosis. We describe the first case of a successfully treated gallbladder adenocarcinoma accompanied by Trousseau syndrome. A 66-year-old woman presented with right hemiplegia. Magnetic resonance imaging identified multiple cerebral infarctions. Her serum carbohydrate antigen 19-9 and D-dimer levels were markedly elevated, and a gallbladder tumor was detected via abdominal computed tomography. Venous ultrasonography of the lower limbs revealed a deep venous thrombus in the right peroneal vein...
April 2024: Acta Medica Okayama
https://read.qxmd.com/read/38688636/membranous-nephropathy-as-a-paraneoplastic-syndrome-in-cancer-of-unknown-primary
#6
JOURNAL ARTICLE
Kyoichi Kaira, Hiroaki Amano, Hisao Imai, Hirokazu Okada, Hiroshi Kagamu
BACKGROUND/AIM: Membranous nephropathy (MN) is a nephrotic syndrome with both idiopathic and secondary etiologies. The mechanism of cancer-associated MN is presumed to involve the immunological production of antibodies against a tumor antigen, although little is known about the detailed mechanism. Lung cancer is a major neoplasm associated with cancer-associated MN. However, the simultaneous occurrence of secondary MN in patients with cancer of unknown primary (CUP) remains unclear. CASE REPORT: Here, we present a case of secondary MN in a 72-year-old female as a paraneoplastic syndrome in CUP...
2024: In Vivo
https://read.qxmd.com/read/38688579/scrna-seq-reveals-novel-immune-suppressive-t-cells-and-investigates-cmv-tcr-t-cells-cytotoxicity-against-gbm
#7
JOURNAL ARTICLE
Xinmiao Long, Zuping Zhang, Yuzhe Li, Kun Deng, Wei Gao, Meng Huang, Xiangyu Wang, Xiang Lin, Xiaoling She, Yiming Zhao, Minfu Zhang, Cheng Huang, Shiyi Wang, Yinfei Du, Peng Du, Shuai Chen, Qing Liu, Minghua Wu
BACKGROUND: Glioblastoma (GBM) is a fatal primary brain malignancy in adults. Previous studies have shown that cytomegalovirus (CMV) is a risk factor for tumorigenesis and aggressiveness for glioblastoma. However, little is known about how CMV infection affects immune cells in the tumor microenvironment of GBM. Furthermore, there has been almost no engineered T-cell receptor (TCR)-T targeting CMV for GBM research to date. METHODS: We evaluated the CMV infection status of patients with GBM's tumor tissue by immune electron microscopy, immunofluorescence, and droplet digital PCR...
April 30, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38687945/combination-low-dose-cyclophosphamide-with-check-point-blockade-and-ionizing-radiation-promote-an-abscopal-effect-in-mouse-models-of-melanoma
#8
JOURNAL ARTICLE
Xing Luo, Ming Zeng
PURPOSE: The complex strategy of hypo-fractionated radiotherapy (HFRT) in combination with an immune checkpoint inhibitor (ICI) can stimulate a potential systemic antitumor response; however, the abscopal effect is always precluded by the tumor microenvironment, which may limit sufficient T-cell infiltration of distant nonirradiated tumors for certain kinds of inhibitory factors, such as regulatory T-cells (Tregs). Additionally, low-dose cyclophosphamide (LD-CYC) can specifically kill regulatory Tregs and strongly synergize antigen-specific immune responses, which could promote an abscopal effect...
April 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38687922/immunostimulatory-effects-of-thermal-ablation-challenges-and-future-prospects
#9
REVIEW
Peng Liu, Zhigang Wei, Xin Ye
This literature explores the immunostimulatory effects of thermal ablation in the tumor microenvironment, elucidating the mechanisms such as immunogenic cell death, tumor-specific antigens, and damage-associated molecular patterns. Furthermore, it outlines critical issues associated with thermal ablation-induced immunostimulatory challenges and offers insights into future research avenues and potential therapeutic strategies.
April 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38687921/new-advances-in-the-treatment-of-chondrosarcoma-under-the-pd-1-pd-l1-pathway
#10
REVIEW
Jiawei Yin, Peng Ren
Bone sarcomas encompass a group of spontaneous mesenchymal malignancies, among which osteosarcoma, Ewing sarcoma, chondrosarcoma, and chordoma are the most common subtypes. Chondrosarcoma, a relatively prevalent malignant bone tumor that originates from chondrocytes, is characterized by endogenous cartilage ossification within the tumor tissue. Despite the use of aggressive treatment approaches involving extensive surgical resection, chemotherapy, and radiotherapy for patients with osteosarcoma, chondrosarcoma, and chordoma, limited improvements in patient outcomes have been observed...
April 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38687588/t-cell-characteristics-impact-response-and-resistance-to-t-cell-redirecting-bispecific-antibodies-in-multiple-myeloma
#11
JOURNAL ARTICLE
Christie P M Verkleij, Chloe A O'Neill, Marloes E C Broekmans, Kristine A Frerichs, Wassilis S C Bruins, Carolien Duetz, Sandy Kruyswijk, Serena R Baglio, Sheri Skerget, Rocio Montes de Oca, Sonja Zweegman, Raluca I Verona, Tuna Mutis, Niels W C J van de Donk
PURPOSE: Bispecific antibodies (BsAbs) directed against B-cell maturation antigen (BCMA; teclistamab) or the orphan G protein-coupled receptor GPRC5D (talquetamab) induce deep and durable responses in heavily pretreated MM patients. However, mechanisms underlying primary and acquired resistance remain poorly understood. EXPERIMENTAL DESIGN: The anti-MM activity of teclistamab and talquetamab was evaluated in bone marrow (BM) samples from MM patients. T-cell phenotype and function were assessed in BM/peripheral blood samples obtained from MM patients who were treated with these BsAbs...
April 30, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38687247/epithelial-expressed-b7-h4-drives-differential-immunotherapy-response-in-murine-and-human-breast-cancer
#12
JOURNAL ARTICLE
Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, Ann Hanna, Brandie C Taylor, Violeta Sanchez, Juliana Bronzini, Susan R Opalenik, Melinda E Sanders, Julia Wulfkuhle, Rosa I Gallagher, Henry Gomez, Claudine Isaacs, Vijaya Bharti, John T Wilson, Tarah J Ballinger, Cesar A Santa-Maria, Payal D Shah, Elizabeth C Dees, Brian D Lehmann, Vandana G Abramson, Gillian L Hirst, Lamorna Brown Swigart, Laura J van ˈt Veer, Laura J Esserman, Emanuel F Petricoin, Jennifer A Pietenpol, Justin M Balko
UNLABELLED: Combinations of immune checkpoint inhibitors (ICI, including anti-PD-1/PD-L1) and chemotherapy have been FDA approved for metastatic and early-stage triple-negative breast cancer (TNBC), but most patients do not benefit. B7-H4 is a B7 family ligand with proposed immunosuppressive functions being explored as a cancer immunotherapy target and may be associated with anti-PD-L1 resistance. However, little is known about its regulation and effect on immune cell function in breast cancers...
April 24, 2024: Cancer Res Commun
https://read.qxmd.com/read/38687056/autophagy-inducing-moo3-x-nanowires-boost-photothermal-triggered-cancer-immunotherapy
#13
JOURNAL ARTICLE
Lizhen He, Qi Chen, Qichen Lu, Meijin Yang, Bin Xie, Tianfeng Chen, Xun Wang
Autophagy could play suppressing role in cancer therapy by facilitating release of tumor antigens from dying cells and inducing immunogenic cell death (ICD). Therefore, discovery and rational design of more effective inducers of cytotoxic autophagy is expected to develop new strategies for finding innovative drugs for precise and successful cancer treatment. Herein, we develop MoO3-x nanowires (MoO3-x NWs) with high oxygen vacancy and strong photothermal responsivity to ablate tumors through hyperthermia, thus promote the induction of cytotoxic autophagy and severe ICD...
April 30, 2024: Angewandte Chemie
https://read.qxmd.com/read/38686714/-detection-and-significance-of-molecular-markers-in-immunotherapy-and-targeted-therapy-of-colorectal-cancer-in-tibet
#14
JOURNAL ARTICLE
Han-Huan Luo, Bin-Yun Liu, Zhen Huo, BIANbazhaxi, Qian Wang, DUObula, NImazhuoma, Zhen DA, Han Wang, Ping-Ping Guo
Objective To study the expression of SWI/SNF-related,matrix-associated,actin-dependent regulator of chromatin,subfamily A,member 4(SMARCA4)/Brahma-related gene 1,V-raf murine sarcoma viral oncogene homolog B(BRAF),P53,programmed cell death protein-1(PD-1),and programmed death-ligand 1(PD-L1),and changes in the expression of BRAF and neurotrophic tyrosine receptor kinase(NTRK) in the patients with colorectal cancer in Tibet,thereby providing a basis for targeted therapy and immunotherapy for this disease in Tibet...
April 2024: Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
https://read.qxmd.com/read/38686388/sars-cov-2-spike-induces-intestinal-barrier-dysfunction-through-the-interaction-between-ceacam5-and-galectin-9
#15
JOURNAL ARTICLE
Yingshu Luo, Zhenling Zhang, Jiangnan Ren, Chunxu Dou, Jiancheng Wen, Yang Yang, Xiaofeng Li, Zhixiang Yan, Yanzhi Han
BACKGROUND: Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), as a typical tumor marker, has been found to exert immunomodulatory effects in many diseases. We previously reported the clinical and molecular evidences supporting that SARS-Cov-2 infected the gastrointestinal (GI) tract and found a reduction of CEACAM5 in COVID-19 patients' feces which associated with gut dysbiosis. Yet the role of CEACAM5 in GI infection is ill-defined. METHODS: Mice models were established through intraperitoneally injecting with recombinant viral spike-Fc to mimic the intestinal inflammation...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38686366/specific-antigens-in-malignancy-associated-membranous-nephropathy
#16
REVIEW
Xiaoying Hu, Guoqin Wang, Hong Cheng
Membranous nephropathy (MN) is a glomerular disease mediated by autoimmune complex deposition, with approximately 30% of cases attributed to secondary causes. Among them, malignant tumors are a significant cause of secondary MN. Recent advancements in the identification of MN-specific antigens, such as THSD7A and NELL-1, suggest a potential association with malignant tumors, yet definitive proof of this relationship remains elusive. Therefore, this article aims to review the distribution of MN-specific antigens in patients with MN caused by malignant tumors and the possible role of these antigens in the pathogenesis of the disease...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38686178/immune-checkpoint-therapy-responders-display-early-clonal-expansion-of-tumor-infiltrating-lymphocytes
#17
JOURNAL ARTICLE
Joel Kidman, Rachael M Zemek, John-William Sidhom, Debora Correa, Nicola Principe, Fezaan Sheikh, Vanessa S Fear, Catherine A Forbes, Abha Chopra, Louis Boon, Ayham Zaitouny, Emma de Jong, Robert A Holt, Matt Jones, Michael J Millward, Timo Lassmann, Alistair R R Forrest, Anna K Nowak, Mark Watson, Richard A Lake, W Joost Lesterhuis, Jonathan Chee
Immune checkpoint therapy (ICT) causes durable tumour responses in a subgroup of patients, but it is not well known how T cell receptor beta (TCRβ) repertoire dynamics contribute to the therapeutic response. Using murine models that exclude variation in host genetics, environmental factors and tumour mutation burden, limiting variation between animals to naturally diverse TCRβ repertoires, we applied TCRseq, single cell RNAseq and flow cytometry to study TCRβ repertoire dynamics in ICT responders and non-responders...
2024: Oncoimmunology
https://read.qxmd.com/read/38686071/lethal-disseminated-intravascular-coagulation-induced-by-primary-and-metastatic-neuroendocrine-prostate-cancer
#18
Takashi Ando, Taro Sasaki, Makoto Naito
INTRODUCTION: Neuroendocrine prostate cancer has a poor prognosis. Although disseminated intravascular coagulation associated with malignancy can be lethal, it very rarely occurs among patients with primary neuroendocrine prostate cancer. CASE PRESENTATION: An 80-year-old man presented to our hospital with bloody sputum. Blood examination indicated disseminated intravascular coagulation. Serum levels of prostate-specific antigen and neuron-specific enolase were 44...
May 2024: IJU case reports
https://read.qxmd.com/read/38685050/blocking-the-mif-cd74-axis-augments-radiotherapy-efficacy-for-brain-metastasis-in-nsclc-via-synergistically-promoting-microglia-m1-polarization
#19
JOURNAL ARTICLE
Lichao Liu, Jian Wang, Ying Wang, Lingjuan Chen, Ling Peng, Yawen Bin, Peng Ding, Ruiguang Zhang, Fan Tong, Xiaorong Dong
BACKGROUND: Brain metastasis is one of the main causes of recurrence and death in non-small cell lung cancer (NSCLC). Although radiotherapy is the main local therapy for brain metastasis, it is inevitable that some cancer cells become resistant to radiation. Microglia, as macrophages colonized in the brain, play an important role in the tumor microenvironment. Radiotherapy could activate microglia to polarize into both the M1 and M2 phenotypes. Therefore, searching for crosstalk molecules within the microenvironment that can specifically regulate the polarization of microglia is a potential strategy for improving radiation resistance...
April 29, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38684875/serum-anti-cfl1-anti-ezr-and-anti-cypa-autoantibody-as-diagnostic-markers-in-ovarian-cancer
#20
JOURNAL ARTICLE
Yifan Cheng, Qing Li, Guiying Sun, Tiandong Li, Yuanlin Zou, Hua Ye, Keyan Wang, Jianxiang Shi, Peng Wang
The purpose of this study was to identify novel autoantibodies against tumor-associated antigens (TAAs) and explore a diagnostic panel for Ovarian cancer (OC). Enzyme-linked immunosorbent assay was used to detect the expression of five anti-TAA autoantibodies in the discovery (70 OC and 70 normal controls) and validation cohorts (128 OC and 128 normal controls). Machine learning methods were used to construct a diagnostic panel. Serum samples from 81 patients with benign ovarian disease were used to identify the specificity of anti-TAA autoantibodies for OC...
April 29, 2024: Scientific Reports
keyword
keyword
99732
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.